Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 12, 1998, Pages 4207-4211

  Arvat, E ^d   Giordano, R ^d   Ramunni, J ^d   Arnaldi, G ^a   Colao, A ^a   Deghenghi, R ^b   Lombardi, G ^a   Mantero, F ^a   Camanni, F ^d   Ghigo, E ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b Ardana   (France)

^c MOLINETTE HOSPITAL   (Italy)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CORTICOTROPIN; DEXAMETHASONE; GROWTH HORMONE RECEPTOR; HEXARELIN; HYDROCORTISONE; NALOXONE; VASOPRESSIN;

ADOLESCENT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CORTICOTROPIN RELEASE; CUSHING SYNDROME; DRUG ACTIVITY; FEMALE; GROWTH HORMONE RELEASE; HORMONE RESPONSE; HUMAN; HYDROCORTISONE RELEASE; HYPOPHYSIS; HYPOPHYSIS ADENOMA; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SOMNOLENCE;

EID: 0005557586     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.12.4207     Document Type: Article

References (36)

1. 1. Bowers CY, Veeraragavan K, Sethumadhavan K. 1993 Atypical growth hormone releasing peptides. In: Bercu BB, Walker RF, eds. Growth hormone II. Basic and clinical aspects. New York: Springer-Verlag; 203-222.
2. 2. Ghigo E, Arvat E, Muccioli G, Camanni F. 1997 Growth hormone-releasing peptides. Eur J Endocrinol. 136:445-460.
3. 3. Smith RG, Van der Ploeg LXT, Howard AD, et al. 1997 Peptidomimetic regulation of growth hormone secretion. Endocr Rev. 18:621-645.
4. 4. Deghenghi R, Boutignon F, Luoni M, Grilli R, Guidi M, Locatelli V. 1995 Small peptides as potent releasers of growth hormone. J Pediatr Endocrinol Metab. 8:311-313.
5. 5. Korbonits M, Grossman AB. 1995 Growth hormone-releasing peptide and its analogues. Novel stimuli to growth hormone release. Trends Endocrinol Metab. 6:43-49.
6. 6. Codd EE, Shu AYL, Walker RF. 1989 Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites. Neuropharmacology. 28:1139-1144.
7. 7. Pong SS, Chaung LYP, Dean DC, Nargunt RP, Patchett AA, Smith RG. 1996 Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol Endocrinol. 10:57-61.
8. 125I]p-benzoyl-phenylalanine Hexarelin derivative. Endocrinology. 139:432-435.
9. 9. Muccioli G, Ghè C, Ghigo MC, et al. 1998 Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. J Endocrínol. 157:99-106.
10. 10. Howard AD, Feighner SD, Cully DF, et al. 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 273:974-977.
11. 11. Arvat E, Maccagno B, Ramunni J, et al. 1997 Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans. Neuroendocrinology. 66:432-438.
12. 12. Korbonits M, Trainer PJ, Besser GM. 1995 The effect of an opiate antagonist on the hormonal changes induced by hexarelin. Clin Endocrinol (Oxf). 43:365-371.
13. 13. Ghigo E, Arvat E, Ramunni J, et al. 1997 Adrenocorticotropin-and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome. J Clin Endocrinol Metab. 82:2439-2444.
14. 14. Arvat E, Di Vito L, Maccagno B, et al. 1997 Effects of GHRP-2 and Hexarelin, two synthetic GH-releasing peptides, on GH, PRL, ACTH and cortisol level in man. Comparison with the effects of GHRH, TRH and hCRH. Peptides. 18:885-891.
15. 15. Hickey GJ, Drisko J, Faidley T, et al. 1996 Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585. J Endocrinol. 148:371-380.
16. 16. Smith RG, Cheng K, Pong SS, et al. 1993 A non-peptidyl growth hormone secretagogue. Science. 260:1640-1643.
17. 17. Elias KA, Ingle GS, Burnier JP, et al. 1995 In vitro characterization of four novel classes of growth hormone-releasing peptide. Endocrinology. 136:5694-5699.
18. 18. De Keyzer Y, Lenne F, Bertagna X. 1997 Widespread transcription of the growth hormone-releasing peptide receptor gene in neuroendocrine human tumors. Eur J Endocrinol. 137:715-718.
19. 19. Thomas GB, Fairhall KM, Robinson ICAF. 1997 Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats. Endocrinology. 138:1585-1591.
20. 20. Arvat E, Maccagno B, Ramunni J, et al. 1998 Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans. Neuroendocrinology. 67:310-316.
21. 21. Orth DN. 1992 Corticotropin-releasing hormone in humans. Endocr Rev. 13:164-191.
22. 22. Dickson SL, Luckman SM. 1997 Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurones in the rat arcuate nucleus following systemic injection of the GH segretagogue, GH-releasing peptide-6. Endocrinology. 138:771-777.
23. 23. Jansson JO, Svensson J, Bengtsson BA, et al. 1998 Acromegaly and Cushing's sindrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumour: in vitro responses to GHRH and GHRP-6. Clin Endocrinol (Oxf). 48:243-250.
24. 24. Selvais P, Donckier J, Buysschaert M, Maiter D. 1998 Cushing's disease: a comparison of pituitary corticotroph microadenomas and macroadenomas. Eur J Endocrinol. 138:153-159.
25. 25. Ikeda H, Yoshimoto T, Ogawa Y, Mizoi K, Murakami O. 1997 Clinicopathological study of Cushing's disease with large pituitary adenoma. Clin Endocrinol (Oxf). 46:669-679.
26. 26. Katznelson L, Bogan JS, Trob JR, et al. 1998 Biochemical assesment of Cushing's disease in patients with corticotroph macroadenomas. J Clin Endocrinol Metab. 83:1619-1623.
27. 27. Colombo P, Passini E, Re T, Faglia G, Ambrosi B. 1997 Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess. Clin Endocrinol (Oxf). 46:661-668.
28. 28. Cuneo RC, Lee W, Harper J, et al. 1997 Metyrapone pre-treated inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome. Clin Endocrinol (Oxf). 46:607-618.
29. 29. Leal Cerro A, Pumar A, Garcia-Garcia E, Dieguez C, Casanueva FF. 1994 Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome. Clin Endocrinol (Oxf). 41:649-654.
30. 30. Procopio M, Invitti C, Maccarìo M, et al. 1995 Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome. Int J Obes. 19:108-112.
31. 31. Magiakou MA, Mastorakos G, Gomez MT, Rose SR, Chrousos GP. 1994 Suppressed spontaneus and stimulated growth hormone secretion in Cushing's disease before and after surgical care. J Clin Endocrinol Metab. 78:131-137.
32. 32. Dieguez C, Mallo F, Senaris R, et al. 1996 Role of glucocorticoids in the neuroregulation of growth hormone secretion. J Pediatr Endocrinol Metab. 9:255-260.
33. 33 Cordido F, Peino R, Penalva A, Alvarez CV, Casanueva FF, Dieguez C. 1996 Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression. J Clin Endocrinol Metab. 81:914-918.
34. 34. Maccario M, Arvat E, Procopio M, et al. 1995 Metabolic modulation of the growth-hormone-releasing activity of hexarelin in man. Metabolism. 44:134-138.
35. 35. Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF. 1995 Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab. 80:942-947.
36. 36. Pombo M, Barreiro J, Penalva A, Peino R, Dieguez C, Casanueva FF. 1995 Absence of growth hormone (GH) secretion after the administration of either GH releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection. J Clin Endocrinol Metab. 80:3180-3184.